FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024673186> ?p ?o ?g. }

• W2024673186 endingPage "391" @default.
• W2024673186 startingPage "386" @default.
• W2024673186 abstract "In the CYP3A5 gene, the A>G (*3) and G>A (*6) polymorphisms result in severely decreased expression of CYP3A5 enzyme relative to a normal functional allele (*1). We sought to determine if the CYP3A5 genetic polymorphisms were associated with level of blood pressure (BP), risk of hypertension (HTN), and the antihypertensive response to verapamil. A total of 676 normotensive and hypertensive participants (mean age 49±8.2 years) from the Hypertension Genes study and 722 patients (mean age 66±9 years) from the International Verapamil/Trandolapril Study Genetic Substudy (INVEST-GENES) were genotyped for CYP3A5 to test for associations with BP, HTN, and in the latter cohort, antihypertensive response to verapamil. CYP3A5 haplotypes were determined using PHASE 2, with any allele containing either (*3) or (*6) designated as non functional. In the HTN genes population, there were no significant differences based on the number of functional CYP3A5 alleles, in systolic blood pressure (SBP) or diastolic blood pressure (DBP) among the normotensive whites or blacks (all P⩾0.70) or in allele frequency between normotensives and hypertensives. In INVEST-GENES, when controlled for baseline BP, race, age, and gender, untreated BP in carriers versus non carriers of a CYP3A5 functional allele was 158.2±13.7 and 154.8±13.7 (P=0.061), respectively. CYP3A5 functional allele status was marginally associated with the SBP response to verapamil in blacks (P=0.075) and Hispanics (P=0.056), but not in whites (P=0.40), with the effect being largely driven by higher SBP in the carriers of two functional alleles. There was no association with DBP response and CYP3A5 allele status. CYP3A5 genotype does not contribute importantly to BP or risk of HTN, but may influence response to calcium channel blockers in populations in which carrier status of two functional alleles is common. Clinical Pharmacology & Therapeutics (2007) 81, 386–391. doi:10.1038/sj.clpt.6100090" @default.
• W2024673186 created "2016-06-24" @default.
• W2024673186 creator A5032639920 @default.
• W2024673186 creator A5035627614 @default.
• W2024673186 creator A5061196407 @default.
• W2024673186 creator A5061865147 @default.
• W2024673186 creator A5072564819 @default.
• W2024673186 creator A5087474720 @default.
• W2024673186 creator A5088669682 @default.
• W2024673186 date "2007-03-01" @default.
• W2024673186 modified "2023-10-18" @default.
• W2024673186 title "Association of CYP3A5 Polymorphisms with Hypertension and Antihypertensive Response to Verapamil" @default.
• W2024673186 cites W1968761150 @default.
• W2024673186 cites W1969370966 @default.
• W2024673186 cites W1983526026 @default.
• W2024673186 cites W1983785977 @default.
• W2024673186 cites W1985385907 @default.
• W2024673186 cites W1987239835 @default.
• W2024673186 cites W2038160619 @default.
• W2024673186 cites W2040545689 @default.
• W2024673186 cites W2044818287 @default.
• W2024673186 cites W2064458956 @default.
• W2024673186 cites W2105902511 @default.
• W2024673186 cites W2110755408 @default.
• W2024673186 cites W2113238803 @default.
• W2024673186 cites W2125114764 @default.
• W2024673186 cites W2143954917 @default.
• W2024673186 cites W2158044437 @default.
• W2024673186 cites W2158882111 @default.
• W2024673186 cites W2358501499 @default.
• W2024673186 cites W2408954460 @default.
• W2024673186 cites W66842089 @default.
• W2024673186 cites W74495713 @default.
• W2024673186 doi "https://doi.org/10.1038/sj.clpt.6100090" @default.
• W2024673186 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17339868" @default.
• W2024673186 hasPublicationYear "2007" @default.
• W2024673186 type Work @default.
• W2024673186 sameAs 2024673186 @default.
• W2024673186 citedByCount "49" @default.
• W2024673186 countsByYear W20246731862012 @default.
• W2024673186 countsByYear W20246731862013 @default.
• W2024673186 countsByYear W20246731862014 @default.
• W2024673186 countsByYear W20246731862015 @default.
• W2024673186 countsByYear W20246731862016 @default.
• W2024673186 countsByYear W20246731862017 @default.
• W2024673186 countsByYear W20246731862019 @default.
• W2024673186 countsByYear W20246731862020 @default.
• W2024673186 countsByYear W20246731862021 @default.
• W2024673186 countsByYear W20246731862022 @default.
• W2024673186 countsByYear W20246731862023 @default.
• W2024673186 crossrefType "journal-article" @default.
• W2024673186 hasAuthorship W2024673186A5032639920 @default.
• W2024673186 hasAuthorship W2024673186A5035627614 @default.
• W2024673186 hasAuthorship W2024673186A5061196407 @default.
• W2024673186 hasAuthorship W2024673186A5061865147 @default.
• W2024673186 hasAuthorship W2024673186A5072564819 @default.
• W2024673186 hasAuthorship W2024673186A5087474720 @default.
• W2024673186 hasAuthorship W2024673186A5088669682 @default.
• W2024673186 hasConcept C104317684 @default.
• W2024673186 hasConcept C126322002 @default.
• W2024673186 hasConcept C134018914 @default.
• W2024673186 hasConcept C135763542 @default.
• W2024673186 hasConcept C149737253 @default.
• W2024673186 hasConcept C180754005 @default.
• W2024673186 hasConcept C197754878 @default.
• W2024673186 hasConcept C2777022698 @default.
• W2024673186 hasConcept C2908647359 @default.
• W2024673186 hasConcept C37463918 @default.
• W2024673186 hasConcept C519063684 @default.
• W2024673186 hasConcept C54355233 @default.
• W2024673186 hasConcept C55775858 @default.
• W2024673186 hasConcept C71924100 @default.
• W2024673186 hasConcept C84393581 @default.
• W2024673186 hasConcept C86803240 @default.
• W2024673186 hasConcept C92137452 @default.
• W2024673186 hasConcept C99454951 @default.
• W2024673186 hasConceptScore W2024673186C104317684 @default.
• W2024673186 hasConceptScore W2024673186C126322002 @default.
• W2024673186 hasConceptScore W2024673186C134018914 @default.
• W2024673186 hasConceptScore W2024673186C135763542 @default.
• W2024673186 hasConceptScore W2024673186C149737253 @default.
• W2024673186 hasConceptScore W2024673186C180754005 @default.
• W2024673186 hasConceptScore W2024673186C197754878 @default.
• W2024673186 hasConceptScore W2024673186C2777022698 @default.
• W2024673186 hasConceptScore W2024673186C2908647359 @default.
• W2024673186 hasConceptScore W2024673186C37463918 @default.
• W2024673186 hasConceptScore W2024673186C519063684 @default.
• W2024673186 hasConceptScore W2024673186C54355233 @default.
• W2024673186 hasConceptScore W2024673186C55775858 @default.
• W2024673186 hasConceptScore W2024673186C71924100 @default.
• W2024673186 hasConceptScore W2024673186C84393581 @default.
• W2024673186 hasConceptScore W2024673186C86803240 @default.
• W2024673186 hasConceptScore W2024673186C92137452 @default.
• W2024673186 hasConceptScore W2024673186C99454951 @default.
• W2024673186 hasIssue "3" @default.
• W2024673186 hasLocation W20246731861 @default.
• W2024673186 hasLocation W20246731862 @default.
• W2024673186 hasOpenAccess W2024673186 @default.

• next